Invention Grant
- Patent Title: Aminobenzimidazole derivatives, treatments, and methods of inhibiting histone deacetylase
-
Application No.: US16644457Application Date: 2018-09-06
-
Publication No.: US11236052B2Publication Date: 2022-02-01
- Inventor: Tong Wang , Stephen Gately
- Applicant: TRANSLATIONAL DRUG DEVELOPMENT, LLC
- Applicant Address: US AZ Scottsdale
- Assignee: TRANSLATIONAL DRUG DEVELOPMENT, LLC
- Current Assignee: TRANSLATIONAL DRUG DEVELOPMENT, LLC
- Current Assignee Address: US AZ Scottsdale
- Agency: Booth Udall Fuller, PLC
- Agent Rodney J. Fuller
- International Application: PCT/US2018/049801 WO 20180906
- International Announcement: WO2019/051125 WO 20190314
- Main IPC: C07D235/30
- IPC: C07D235/30 ; C07D405/06 ; A61P35/00
Abstract:
The present invention is directed to novel aminobenzimidazole derivatives. The present invention is also directed to methods of treating a histone deacetylase (HDAC)-associated disease or inhibiting the histone deacetylating activity of a HDAC isoform in a cell or with one or more of the aminobenzimidazole derivatives.
Public/Granted literature
- US20210061770A1 AMINOBENZIMIDAZOLE DERIVATIVES, TREATMENTS, AND METHODS OF INHIBITING HISTONE DEACETYLASE Public/Granted day:2021-03-04
Information query
